A New Scientific Study On Oncotarget Links Marijuana To Sexual Arousal

In most conversations on how health and lifestyle trends impact sexual patterns, the subject of marijuana will always come up. Just like tobacco, many people assume that marijuana would have no or negative effect on sexual function. However, a study conducted by researchers at Stanford University indicated that individuals who use marijuana have 20 percent more sex drive than those who abstain from the drug. The research involved 50,000 reproductive-aged Americans from both sexes and races, ages, income groups, education levels, religions and different health status. Michael Eisenberg, the senior author of the research, said that the sexual impact depends on the frequency of the drug use. Check the journal at SCImago Journal & Country Rank.

As more states legalize marijuana drug for medical or recreational use, many Americans are likely to consume the drug. Recently, Gallup poll indicated that one out of eight Americans use marijuana while 45 percent have tried it at least once. However, Eisenberg notes that the study does not necessarily mean that the drug causes users to have more sex; it only means that it stimulates arousal pathways. This information was originally reported on Research Gate as outlined in the following link https://www.researchgate.net/blog/post/marijuana-users-have-more-sex

About Oncotarget

Oncotarget is a multidisciplinary biomedical journal with free access. The journal publishes research papers with the objective of enhancing the impact of scientific research by making it rapidly and widely available. Oncotarget’s insightful review has helped it to gain more popularity among scientists who rely on it to grow their scientific research experience. These researchers use the platform to contribute to the progress of science courtesy of assistance from Oncotarget’s prominent scientists. Since the journal publishes articles touching on a wide range of topics, it encourages collaboration by eliminating the border between biomedical specialties. Follow Oncotarget journal on Twitter.

Recently, Oncotarget announced that it would be publishing two issues per week. These issues will be available in various high-profile indexes and archives, including PubMed, PubMed Central, Scopus, ISI/Web of Science: Science Citation Index Expanded, BIOSIS Previews, Biological Abstracts and EMBASE. Oncotarget has partnered with the National Library of Medicine to become the first bio-medical journal to submit an issue to PubMed few days after publishing it online. The journal will appear permanently on PubMed after assigning page and issue numbers. They publish research on oncology, aging, pathology, autophagy, immunology and microbiology, and chromosomes.

Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget

Performance Review of Oncotarget

The US-based medicine oncology journal was ranked 66 on the H Index, according to SJR (Scimago Journal & Country Rank). The number of times that the Oncotarget documents have been cited showed an upward trend between 2009 and 2016, with the total cites standing at 22697. The number of non-citable documents was 15 (2011), 205 (2012), 338 (2013), 124 (2014), 137 (2015) and 392 (2016) – 1211 in total. The level of international collaboration for the Medical Journal was 22.58% in 2011 and 31.37% in 2016 with the highest being 37.4% in 2014.

RG Journal Impact for Oncotarget was estimated at 3.45*. Research Gate used its data to calculate the value based on the average number of times that the works published in the journal have been cited. It is however imperative to note that the data relied upon in the calculation may not be exhaustive.

Note that the 2017 RG Journal Impact is not out yet,the results will be available during the summer of 2018. The Research Gate Journal Impact for Oncotarget has been fluctuating for the past few years. The figures were estimated at 4.76, 6.73, 5.77, and 5.30 in 2011, 2012, 2013, 2014 and 2015 respectively. Other important details include the journal’s cited half-life (2.40), immediacy index (0.57), Eigen factor (0.01) and article influence (1.72).

About Oncotarget

It is a weekly peer-reviewed open access journal committed to the provision of reliable information in the field of medicine. The medical journal covers research on all areas of oncology. The motivation behind its establishment was to avail an in-depth understanding of the diagnosis and treatment of cancer. Established in 2010, Oncotarget is usually published by Impact Journals. Its chief editors are Andrei V, Gudkov and Mikhail Blagosklonny of Roswell Park Cancer Institute.

The growing popularity of the journal is attributed to its insightful, punctual, constructive and multiple peer review which has helped its authors to enhance the effect of their research. Oncotarget plans to start publishing two issues weekly on Tuesdays and Fridays because of its increasing importance, impact, volume, and quality. The move is expected to bridge the gap and also prevent delays in the future.